A Chinese traditional external use medicine for treating medium term and late brain tumor

Abstract

This invention relates to a Chinese traditional external use medicine for treating medium term and late brain tumor. It includes the main medicine and excipient, the said main medicine is composed with the flowing raw materials by the unit of weight: whole scorpion(25-35), radix aconiti sinensis (16-20), radix aconiti agrestis16-20), meretrix shell(16-20), putamen manidis (15-25), bombyx batryticatus (10-20), dog button (4-8), gecko (3-7), argum groundsel herb (3-8), knoxia root (3-7), Euphorbia kansui Liou (2-6), galla sinensis (1-3), twotooth achyranthes root (1-3), borneol (0.5-1.5), catharsius (0.5-1.5), blister beetle (0.5-1.5), camphor (5-15), musk (6-10) and calculus bovis (10-14). The said excipient is prepared by the following raw materials through using the unit of weight: safflower (3.7), glycyrhiza(3.7), centipede (3.7), succus spissatus of Shanxi vinegar(486 use size as its unit). After preparing the said main medicine and excipient, externally apply to the affected part, the medicine through penetration will make the hydrocephalus discharged, epilepsia eliminated, so to cut off the existence of the cancer cell and kill the target cell of the cancer cell, and at the same time make the dead cancer cell excreted outside of the body, so to have the organist immunity improved, and finally reach the aim of the recovery of the brain tumor.

Description

technical field [0001] The invention relates to a traditional Chinese medicine for external use, in particular to a traditional Chinese medicine for external use for treating middle and advanced brain tumors. The trade name of the invention is Zhonghua Tuan Tuo Plaster. Background technique [0002] The treatment of brain tumors is a difficult problem facing modern medicine. According to the statistics of the World Health Organization in 2003, according to different regions, races and environmental pollution levels, the annual incidence of benign and malignant primary brain tumors is 25-35 per 100,000 people. Among them, primary malignant brain tumors accounted for more than 60%. Although the two major revolutions in the field of neurosurgery, that is, the advancement of imaging diagnostic technology marked by the advent of CT and the application of micro-neurosurgery technology, have greatly promoted the development of neurosurgery, but traditional Western medicine has no ...

AI Technical Summary

Problems solved by technology

[0003] At present, the treatment method for brain tumors in the world is neurosurgical craniotomy. Due to the physiological and anatomical structure of the brain, it is very difficult to remove all brain tumors. For recurrence and spread, the only way to cooperate with neurosurgery is radiotherapy and chemotherapy

While chemotherapy and radiotherapy can inhibit the growth of cancer cells, it also greatly damages the normal cells of the human body. When the normal body can no longer withstand the chemotherapy and radiotherapy, the cancer cells will naturally relapse, followed by a second craniotomy, thereby accelerating death

This method cannot cure brain tumors (malignant) and can only prolong the life of patients relatively

Oral TCM treatment of brain tumors in my country has entered the stage of clinical application. However, due to the natural repulsion function of the skull to shield the drug from entering the lesion through the digestive system and blood system, the course of treatment is long and the curative effect is not significant in the short term. Strong toxicity will cause damage to the patient's digestive system, making it impossible for the patient to complete the full course of treatment

Images